• Title of article

    Drug-resistant epilepsy and epileptic phenotype-EEG association in MECP2 mutated Rett syndrome

  • Author/Authors

    Sabrina Buoni، نويسنده , , Raffaella Zannolli، نويسنده , , Claudio De Felice، نويسنده , , Simona Saponari، نويسنده , , Mirella Strambi، نويسنده , , Maria Teresa Dotti، نويسنده , , Elena Castrucci، نويسنده , , Letizia Corbini، نويسنده , , Alessandra Orsi، نويسنده , , Joseph Hayek، نويسنده ,

  • Issue Information
    روزنامه با شماره پیاپی سال 2008
  • Pages
    4
  • From page
    2455
  • To page
    2458
  • Abstract
    Objective To determine in MECP2-mutated Rett syndrome (RTT [MIM 312750]): (1) the prevalence of drug-resistant epilepsy (DRE); (2) whether the presence of DRE is related to the abnormal EEG patterns or to the particular MECP2 mutant genotype. Methods Retrospective survey of a large population of patients (n = 154) evaluated between 1978 to 2007 (May) at the Child Psychiatry and Neurology Unit of Siena (Italy) with both clinical and genetic (i.e. MECP2 mutated) diagnoses of RTT. Some subjects were followed for up to 20 years. Among those, cases with epilepsy were first selected for study; within that group, cases with DRE were identified and studied. The association between clinical severity of their epilepsy and quantitative or qualitative scores of EEG severity was tested using rank coefficients (Spearman’s rho values). The relationship between DRE and RTT genotype category (i.e. gene deletion, gene duplication, early truncating mutation, late truncating mutation, and missense mutation) or a specific MECP2 genotype was tested using the chi-square test. A p-value <0.05 (two sided) was considered to indicate statistical significance. Results Prevalence of DRE was 16% (i.e. 16 DRE out of 100 MECP2-mutated RTT epileptic patients). No significant relationship was found between clinical severity of DRE and quantitative (p = 0.9190) or qualitative EEG scores (p = 0.1511). In addition, no significant relationship was found between the DRE and the RTT genotype category (chi-square = 1.147, DF = 4, p = 0.8867), or a specific MECP2 genotype (chi-square = 30.958, DF = 39, p = 0.8173). Conclusions Although RTT MECP2-mutated patients suffer from a serious and progressive encephalopathy, it is “epileptogenic” but not “DREgenic” as they have a decreased risk (16%) for DRE compared to the general epileptic population (DRE: 20-40%). The presence of DRE is not related to abnormal EEG findings or a particular MECP2 mutant genotype. Significance These observations could be of help in the practical management and family counseling.
  • Keywords
    Rett syndromeEEG patternDrug-resistant epilepsyMECP2 gene
  • Journal title
    Clinical Neurophysiology
  • Serial Year
    2008
  • Journal title
    Clinical Neurophysiology
  • Record number

    524884